Journal of visualized experiments : JoVE
Cure8 research brief
Why This Matters
People with pediatric IBD-like intestinal inflammation, or caregivers, may encounter overlapping autoimmune conditions such as large-vessel vasculitis; recognizing that intestinal biopsy can be nondiagnostic is important.
The case shows biologic therapies (adalimumab, tocilizumab) and steroids used sequentially for combined vascular and intestinal inflammation.
Who Should Pay Attention
Pediatric patients with IBD-like symptoms, parents and caregivers, pediatric gastroenterologists, pediatric rheumatologists, and clinicians managing overlapping autoimmune conditions.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This article describes a single-child case (14 years old) with biopsy-proven chronic active proctitis and concurrent large-vessel vasculitis meeting classification criteria for Takayasu arteritis.
The intestinal findings were insufficient to confirm ulcerative colitis or Behçet’s disease, and the authors note excluding Behçet’s because mucocutaneous and ocular features were absent. Treatment in the reported case began with prednisone plus the anti-TNF biologic adalimumab, which produced remission.
When inflammatory markers and vascular wall thickening worsened during a later flare, clinicians increased prednisone and added the IL-6 inhibitor tocilizumab, after which the patient was reported stable at follow-up.
The paper is a case report with literature review, not a trial; it illustrates diagnostic and management challenges when vasculitis and nonspecific intestinal inflammation coexist. It does not provide generalizable treatment recommendations.
Keep In Mind
This is a single case report (with literature review) reported as an abstract on PubMed. Findings are descriptive and specific to this patient; they do not establish treatment efficacy. The diagnosis used established classification criteria for Takayasu arteritis.
Behçet’s disease was excluded clinically in this patient; the intestinal inflammation remained of uncertain etiology.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of visualized experiments : JoVE
AuthorsMeimei Yao, Fei Liu, Tianji Gao +5 more
InstitutionRheumatology and Immunology Department, Beijing Children's Hospital, Capital Medical University.
Study typeJournal article, case reports, video Audio media, review
Indexed viaPubMed
Source typeResearch paper
PublishedAug 21, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Exploring beyond tumors: Intra-abdominal mass in a young patient with Crohn's disease
IBD can present in uncommon ways in children — including as an intraluminal abdominal mass that mimics tumors. Early recognition avoids misdiagnosis and guides appropriate surgical and medical follow-up.
To Your Good Health: Aggressive treatment for Crohn's - Tribune Chronicle -
Guidelines recommend treating objective inflammation even when symptoms are mild because untreated disease can cause complications; the article describes escalation to risankizumab due to endoscopic inflammation, high...
STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP
The study tests whether adding MRI-based transmural assessment to a fecal-calprotectin–guided (CALM) strategy improves the ability to keep people with Crohn’s disease in corticosteroid-free clinical remission and may...